Peter A. Calabresi

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al. · Neurology · 2014 · 3K citations · Full text

Neuroimaging Biomarkers, Scleroderma, Neurological Disease +15

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine · 2010 · 2.6K citations · Full text

Tract probability maps in stereotaxic spaces: Analyses of white matter anatomy and tract-specific quantification

Kegang Hua, Jiangyang Zhang, Setsu Wakana et al. · NeuroImage · 2007 · 1.5K citations · Full text

Gross Anatomy, Cognitive Science, Tract-specific Quantification +13

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Nikolaos A. Patsopoulos, Sergio E. Baranzini, Adam Santaniello et al. · Science · 2019 · 1.3K citations · Full text

Immunology, Extended Mhc, Innate Immunity +16

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Richard A. Rudick, William H. Stuart, Peter A. Calabresi et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text